Dcp2 decapping protein modulates mRNA stability of the critical interferon regulatory factor (IRF) IRF-7

Molecular and Cellular Biology

Volumn 32, Issue 6, 2012, Pages 1164-1172

  Li, You ^a,c   Dai, Jihong ^b   Song, Mangen ^a   Fitzgerald Bocarsly, Patricia ^b   Kiledjian, Megerditch ^a  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DCP2 PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 7; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FIBROBLAST; INNATE IMMUNITY; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; RNA DEGRADATION; RNA STABILITY; VIRUS INFECTION;

ANIMALS; CELLS, CULTURED; EMBRYO, MAMMALIAN; ENDORIBONUCLEASES; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENES, MHC CLASS II; HOST-PATHOGEN INTERACTIONS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-7; LENTIVIRUS; LENTIVIRUS INFECTIONS; MICE; RNA STABILITY; RNA, MESSENGER;

MAMMALIA;

EID: 84863288824     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06328-11     Document Type: Article

References (39)

1. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
2. Biggioggero M, Gabbriellini L, Meroni PL. 2010. Type I interferon therapy and its role in autoimmunity. Autoimmunity 43:248-254.
3. Borden EC, et al. 2007. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6:975-990.
4. Carballo E, Lai WS, Blackshear PJ. 2000. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 95:1891-1899.
5. Carballo E, Lai WS, Blackshear PJ. 1998. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281:1001-1005.
6. Colina R, et al. 2008. Translational control of the innate immune response through IRF-7. Nature 452:323-328.
7. Daffis S, et al. 2008. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J. Virol. 82:8465-8475.
8. Decker CJ, Parker R. 1993. A turnover pathway for both stable and unstable mRNAs in yeast: evidence for a requirement for deadenylation. Genes Dev. 7:1632-1643.
9. Dunckley T, Parker R. 1999. The DCP2 protein is required for mRNA decapping in Saccharomyces cerevisiae and contains a functional MutT motif. EMBO J. 18:5411-5422.
10. Fenger-Grøn M, Fillman C, Norrild B, Lykke-Andersen J. 2005. Multiple processing body factors and the ARE-binding protein TTP activate mRNA decapping. Mol. Cell 20:905-915.
11. Fensterl V, Sen GC. 2009. Interferons and viral infections. Biofactors 35:14-20.
12. Garneau NL, Wilusz J, Wilusz CJ. 2007. The highways and byways of mRNA decay. Nat. Rev. Mol. Cell Biol. 8:113-126.
13. Herrick DJ, Ross J. 1994. The half-life of c-myc mRNA in growing and serum-stimulated cells: influence of the coding and 3′ untranslated regions and role of ribosome translocation. Mol. Cell. Biol. 14:2119-2128.
14. Honda K, Takaoka A, Taniguchi T. 2006. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25:349-360.
15. Honda K, et al. 2005. IRF-7 is the master regulator of type-I interferondependent immune responses. Nature 434:772-777.
16. Hsu CL, Stevens A. 1993. Yeast cells lacking 5′→3′ exoribonuclease 1 contain mRNA species that are poly(A) deficient and partially lack the 5′ cap structure. Mol. Cell. Biol. 13:4826-4835.
17. Izaguirre A, et al. 2003. Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J. Leukoc. Biol. 74:1125-1138.
18. Justesen J, Hartmann R, Kjeldgaard NO. 2000. Gene structure and function of the 2′-5′-oligoadenylate synthetase family. Cell. Mol. Life Sci. 57:1593-1612.
19. Kabnick KS, Housman DE. 1988. Determinants that contribute to cytoplasmic stability of human c-fos and beta-globin mRNAs are located at several sites in each mRNA. Mol. Cell. Biol. 8:3244-3250.
20. Khabar KS, Young HA. 2007. Post-transcriptional control of the interferon system. Biochimie 89:761-769.
21. Levy DE, Marie I, Smith E, Prakash A. 2002. Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback. J. Interferon Cytokine Res. 22:87-93.
22. Li Y, Ho ES, Gunderson SI, Kiledjian M. 2009. Mutational analysis of a Dcp2-binding element reveals general enhancement of decapping by 5′- end stem-loop structures. Nucleic Acids Res. 37:2227-2237.
23. Li Y, Song M, Kiledjian M. 2011. Differential utilization of decapping enzymes in mammalian mRNA decay pathways. RNA 17:419-428.
24. Li Y, Song MG, Kiledjian M. 2008. Transcript-specific decapping and regulated stability by the human Dcp2 decapping protein. Mol. Cell. Biol. 28:939-948.
25. Lin WJ, et al. 2011. Posttranscriptional control of type I interferon genes by KSRP in the innate immune response against viral infection. Mol. Cell. Biol. 31:3196-3207.
26. Liu H, Kiledjian M. 2006. Decapping the message: a beginning or an end. Biochem. Soc. Trans. 34:35-38.
27. Liu Q, Greimann JC, Lima CD. 2006. Reconstitution, activities, and structure of the eukaryotic RNA exosome. Cell 127:1223-1237.
28. Lykke-Andersen J. 2002. Identification of a human decapping complex associated with hUpf proteins in nonsense-mediated decay. Mol. Cell. Biol. 22:8114-8121.
29. Lykke-Andersen J, Wagner E. 2005. Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev. 19:351-361.
30. Megjugorac NJ, Young HA, Amrute SB, Olshalsky SL, Fitzgerald-Bocarsly P. 2004. Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells. J. Leukoc. Biol. 75:504-514.
31. Nguyen H, Hiscott J, Pitha PM. 1997. The growing family of interferon regulatory factors. Cytokine Growth Factor Rev. 8:293-312.
32. Schott J, Stoecklin G. 2010. Networks controlling mRNA decay in the immune system. Wiley Interdiscip. Rev. RNA 1:432-456.
33. Shyu AB, Greenberg ME, Belasco JG. 1989. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev. 3:60-72.
34. Singh J, et al. 2008. DcpS as a therapeutic target for spinal muscular atrophy. ACS Chem. Biol. 3:711-722.
35. Song MG, Li Y, Kiledjian M. 2010. Multiple mRNA decapping enzymes in mammalian cells. Mol. Cell 40:423-432.
36. van Dijk E, et al. 2002. Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J. 21:6915-6924.
37. Vinkemeier U, Meyer T. 2005. Antiviral activity of oligomerizationdeficient Stat1. Genome Inform. 16:44-48.
38. Wang Z, Jiao X, Carr-Schmid A, Kiledjian M. 2002. The hDcp2 protein is a mammalian mRNA decapping enzyme. Proc. Natl. Acad. Sci. U. S. A. 99:12663-12668.
39. Wang Z, Kiledjian M. 2001. Functional link between the mammalian exosome and mRNA decapping. Cell 107:751-762.